Abstract
This chapter reviews approaches to neuroprotection that are based on reducing the excitotoxic effects of glutamate and related compounds. Evidence for a role of excitotoxicity in the brain damage that accompanies cerebral ischemia and trauma has been presented elsewhere (Choi and Rothman, 1990; Meldrum, 1990; Meldrum and Garthwaite, 1990; Olney, 1990) and will not be further reviewed here. Nor shall we provide any review or analysis of the different animal models of cerebral ischemia and trauma in which putative cerebroprotective agents are currently evaluated [these aspects are reviewed by Meldrum, 1990, and in Chapters 3 (Hsu et al.), 4 (Zivin), and 5 (Hayes et al.) of this volume]. Here we shall consider the various pharmacologic options for reducing excitatory effects, reviewing the drugs available for modifying the different stages of the excitotoxic process and the evidence for their cerebroprotective efficacy in animal models.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adamson P, Hajimohammadreza I, Brammer MJ, Campbell I, Meldrum BS (1990): Presynaptic glutamate/quisqualate receptors: Effects on synaptosomal free calcium concentrations. J Neurochem 55: 1850–1854
Andine P, Lehmann A, Ellren K, Wennberg E, Kjellmer I, Nielsen T, Hagberg H (1988): The excitatory amino acid antagonist kynurenic acid administered after hypoxia-ischemia in neonatal rats offers neuroprotection. Neurosci Lett 90: 208–212
Arai A, Kessler M, Lee K, Lynch G (1990): Calpain inhibitors improve the recovery of synaptic transmission from hypoxia in hippocampal slices. Brain Res 532: 63–68
Arvin B, Le Peillet E, DĂĽrmĂĽller N, Chapman AG, Meldrum BS (1992): Electrolytic lesions of the locus coeruleus, or 6-hydroxy dopamine lesions of the medial forebrain bundle protect against excitotoxic damage in rat hippocampus. Brain Res (in press)
Aston-Jones G, Akaoka H, Charléty P, Chouvet G (1991): Serotonin selectively attenuates glutamate-evoked activation of noradrenergic locus coeruleus neurons. J Neurosci 11: 760–769
Beaughard M, Michelin MT, Massingham R (1990): Effects of the putative glycine antagonist HA-966 on the neurological and histological changes induced by transient global cerebral ischemia in rats and gerbils. In: Pharmacology of Cerebral Ischemia 1990, Krieglstein J, Oberpichler H, eds. Stuttgart: Wissenschaftliche Verlagsgesellschaft, p 275
Bielenberg GW, Burkhardt M (1990): 5-HT1A agonists show neuroprotectant activity in rats and mice. Eur J Pharmacol 183: 1953–1954
Block GA, Pulsinelli WA (1988): Excitatory amino acid and purinergic transmitter involvement in ischemia-induced selective neuronal death. In: Mechanisms of Cerebral Hypoxia and Stroke, Somjen G, ed. New York: Plenum Press, p 359
Boast CA, Gerhardt SC, Janak P (1987): Systemic AP7 reduces ischemic brain damage in gerbils. In: Excitatory Amino Acid Transmission, Hicks TP, Lodge D, McLennan H, eds. New York: Alan R. Liss, p 249
Boast CA, Gerhardt SC, Pastor G, Lehmann J, Etienne PE, Liebman JM (1988): The N-methyl-n-aspartate antagonists CGS 19755 and CPP reduce ischemic brain damage in gerbils. Brain Res 442: 345–348
Bode-Greuel KM, Klisch J, Glaser T, Traber J (1990): Serotonin (5-HT) lA receptor agonists as neuroprotective agents in cerebral ischemia. In: Pharmacology of Cerebral Ischemia 1990, Krieglstein J, Oberpichler H, eds. Stuttgart: Wissenschaftliche Verlagsgesellschaft, p 485
Boulter J, Hollmann M, O’Shea-Greenfield A, Hartley M, Deneris E, Maron C, Heinemann S (1990): Molecular cloning and functional expression of glutamate receptor subunit genes. Science 249: 1033–1037
Buchan A, Pulsinelli WA (1990): Hypothermia but not the N-methyl-D-aspartate antagonist, MK-801, attenuates neuronal damage in gerbils subjected to transient global ischemia. J Neurosci 10: 311–316
Buchan AM, Li H, Pulsinelli WA (1991): The N-methyl-n-aspartate antagonist, MK-801, fails to protect against neuronal damage caused by transient severe forebrain ischemia in adult rats. J Neurosci 11: 1049–1056
Buchan AM, Xue D, Slivka A (1990): MK-801 reduces the volume of neocortical infarction but also increases regional cerebral blood flow. Stroke 21, 163
Bullock R, Graham DI, Chen M-H, Lowe D, McCulloch J (1990): Focal cerebral ischemia in the cat: Pretreatment with a competitive NMDA receptor antagonist, D-CPPene. J Cereb Blood Flow Metab 10: 668–674
Carter C, Benavides J, Legendre P, Vincent JD, Noel F, Thuret F, Lloyd KG, Arbilla S, Zivkovic B, MacKenzie ET, Scatton B, Langer SZ (1988): Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. II. Evidence for N-methyl-Daspartate receptor antagonist properties. J Pharmacol Exp Ther 247: 1222–1232
Carter CJ, Lloyd KG, Zivkovic B, Scatton B (1990): Ifenprodil and SL 82.0715 as cerebral antiischemic agents. III. Evidence for antagonistic effects at the polyamine modulatory site within the N-methyl-D-aspartate receptor complex. J Pharmacol Exp Ther 253: 475–482
Chapman AG, Dürmüller N, Lees GJ, Meldrum BS (1989): Excitotoxicity of NMDA and kainic acid is modulated by nigrostriatal dopaminergic fibres. Neurosci Lett 107: 256–260
Chapman AG, Meldrum BS (1989): Non-competitive N-methyl-n-aspartate antagonists protect against sound-induced seizures in DBA/2 mice. Eur J Pharmacol 166: 201–211
Choi DW (1990): Cerebral hypoxia: Some new approaches and unanswered questions. J Neurosci 10: 2493–2501
Choi DW, Rothman SM (1990): The role of glutamate neurotoxicity in hypoxicischemic neuronal death. Annu Rev Neurosci 13: 171–182
Diemer NH, Johansen FF, Jorgensen MB (1990): N-Methyl-D-aspartate and nonN-methyl-D-aspartate antagonists in global cerebral ischemia. Stroke 21 (Suppl 3):III39–III42
Duverger D, McKenzie ET (1988): The quantification of cerebral infarction following focal ischemia in the rat: Influence of strain, arterial pressure, blood glucose concentration, and age. J Cereb Blood Flow Metab 8: 449–461
Eaton SA, Salt TE (1989): Modulatory effects of serotonin on excitatory amino acid responses and sensory synaptic transmission in the ventrobasal thalamus. Neuroscience 33: 285–292
Egebjerg J, Bettler B, Hermans-Borgmeyer I, Heinemann S (1991): Cloning of a cDNA for a glutamate receptor subunit activated by kainate but not AMPA. Nature 351: 745–748
Faden AI, Demediuk P, Panter SS, Vink R (1989): The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science 244: 798–800
Faden AI, Simon RP (1988): A potential role for excitotoxins in the pathophys-iology of spinal cord injury. Ann Neurol 23: 623–626
Favaron M, Manev H, Siman R (1990): Down regulation of protein kinase C protects cerebellar granule neurons in primary culture from glutamate-induced neuronal death. Proc Natl Acad Sci USA 87: 1983–1987
Fleischer JE, Tateishi A, Drummond JC, Scheller MS, Grafe MR, Zornow MH, Shearman GT, Shapiro HM (1989): MK-801, an excitatory amino acid antagonist, does not improve neurologic outcome following cardiac arrest in cats. J Cereb Blood Flow Metab 9: 795–804
Forsythe ID, Clements JD (1990): Presynaptic glutamate receptors depress excitatory monosynaptic transmission between mouse hippocampal neurones. JPhysiol (London) 429: 1–16
Foster AC (1991): Channel blocking drugs for the NMDA receptor. In: Excitatory Amino Acid Antagonists, Meldrum BS, ed. Oxford: Blackwell Scientific Publications, p 164
Frandsen A, Schousboe A (1991): Dantrolene prevents glutamate cytotoxicity and Ca2+ release from intracellular stores in cultured cerebral cortical neurons. J Neurochem 56: 1075–1078
Gannon RL, Baty LT, Terrian DM (1989): L(+)-2-Amino-4-phosphonobutyrate inhibits the release of both glutamate and dynorphin from guinea pig but not rat hippocampal mossy fiber synaptosomes. Brain Res 495: 151–155
Germano IM, Pitts LH, Meldrum BS, Bartkowski HM, Simon RP (1987): Kynurenate inhibition of cell excitation decreases stroke size and deficits. Ann Neurol 22: 730–734
Gill R, Foster AC, Woodruff GN (1987): Systemic administration of MK-801 protects against ischemia-induced hippocampal neurodegeneration in the gerbil. J Neurosci 7: 3343–3349
Gill R, Foster AC, Woodruff GN (1988): MK-801 is neuroprotective in gerbils when administered during the post-ischemic period. Neuroscience 25: 847–856
Gill R, Lodge D (1991): The neuroprotective action of 2,3-dihydroxy-6-nitro-7sulfamoyl-benzo(F)quinoxaline (NBQX) in a rat focal ischemia model. Brit J Pharmacol 102: 61 P
Globus MYT, Ginsberg MD, Dietrich WD, Busto R, Scheinberg P (1987): Sub-stantia nigra lesion protects against ischemic damage in the striatum. Neurosci Lett 80: 251–256
Gotti B, Benavides J, MacKenzie ET, Scatton B (1990): The pharmacotherapy of focal cortical ischemia in the mouse. Brain Res 522: 290–307
Gotti B, Duverger D, Bertin J, Carter C, Dupont R, Frost J, Gaudilliere B, MacKenzie ET, Rousseau J, Scatton B, Wick A (1988): Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. I. Evidence for efficacy in models of focal cerebral ischemia. J Pharmacol Exp Ther 247: 1211–1221
Grotta JC (1987): Current medical and surgical therapy for cerebrovascular disease. N Engl J Med 317: 1505–1516
Grotta JC, Picone CM, Ostrow PT, Strong RA, Earls RM, Yao LP, Rhoades HM, Dedman JR (1990): CGS-19755, a competitive NMDA receptor antagonist, reduces calcium-calmodulin binding and improves outcome after global cerebral ischemia. Ann Neurol 27: 612–619
Gustafson I, Miyauchi Y, Wieloch TW (1989): Postischemic administration of idazoxan, an a-2 adrenergic receptor antagonist, decreases neuronal damage in the rat brain. J Cereb Blood Flow Metab 9: 171–174
Hagberg H, Andine P, Fredholm B, Rudolphi K (1990): Effect of the adenosine uptake inhibitor propentofylline on extracellular adenosine and glutamate and evaluation of its neuroprotective effect after ischemia in neonatal and adult rats. In: Pharmacology of Cerebral Ischemia 1990, Krieglstein J, Oberpichler H, eds. Stuttgart: Wissenschaftliche Verlagsgesellschaft, p 427
Hall ED, Pazara KE (1988): Quantitative analysis of effects of kappa-opioid agonists and post-ischemic hippocampal CA1 neuronal necrosis in gerbils. Stroke 19: 1008–1012
Hatfield RH, Mendelow AD, Alvares L (1990): Triphenyltetrazolium chloride (TTC) as a marker of ischemic changes in rat brain after MCA occlusion. J Neurol Neurosurg Psychiatry 53: 446
Honoré T, Davies SN, Drejer J, Fletcher EJ, Jacobsen P, Lodge D, Nielsen FE (1988): Quinoxalinediones: Potent competitive non-NMDA glutamate receptor antagonists. Science 241: 701–703
Ikonomidou C, Price MT, Mosinger JL, Frierdich G, Labruyere J, Shahid Salles K, Olney JW (1989): Hypobaric-ischemic conditions produce glutamate-like cytopathology in infant rat brain. J Neurosci 9: 1693–1700
Keana JFW, McBurney RN, Scherz MW, Fischer JB, Hamilton PN, Smith SM, Server AC, Finkbeiner S, Stevens CF, Jahr C, Weber E (1989): Synthesis and characterization of a series of diarylguanidines that are noncompetitive N-methylD-aspartate receptor antagonists with neuroprotective properties. Proc Natl Acad Sci USA 86: 5631–5635
Keinanen K, Wisden W, Sommer B, Werner P, Herb A, Verdoorn TA, Sakmann B, Seeburg PH (1990): A family of AMPA-selective glutamate receptors. Science 249: 556–560
Kirino T, Tamura A, Sano K (1986): A reversible type of neuronal injury following ischemia in the gerbil hippocampus. Stroke 17: 455–459
Kuroiwa T, Bonnekoh P, Hossmann K-A (1990): Therapeutic window of CA1 neuronal damage defined by an ultrashort-acting barbiturate after brain ischemia in gerbils. Stroke 21: 1489–1493
Lanier WL, Perkins WJ, Karlsson BR, Milde JH, Scheithauer BW, Shearman GT, Michenfelder JD (1990): The effects of dizocilpine maleate (MK-801), an antag-onist of the N-methyl-D-aspartate receptor, on neurologic recovery and histopathology following complete cerebral ischemia in primates. J Cereb Blood Flow Metab 10: 252–261
Lee KS, Frank S, Vanderklish P, Arai A, Lynch G (1991): Inhibition of proteolysis protects hippocampal neurons from ischemia. Proc Natl Acad Sci USA 88: 7233–7237
Leach MJ, Marden CM, Miller AA (1986): Pharmacological studies on lamotrigine, a novel potential antiepileptic drug. II. Neurochemical studies on the mechanism of action. Epilepsia 27: 490–497
Le Peillet E, Arvin B, Moncada C, Meldrum BS (1992): The non-NMDA antagonists, NBQX and GYKI 52466, protect against cortical and striatal cell loss following transient global ischaemia in the rat. Brain Res 571: 115–120
Lester RA, Jahr CE (1990): Quisqualate receptor-mediated depression of calcium currents in hippocampal neurons. Neuron 4: 741–749
Levine S (1960): Anoxic-ischemic encephalopathy in rats. Am J Pathol 36: 1–17
Liman ER, Knapp AG, Dowling JE (1989): Enhancement of kainate-gated currents in retinal horizontal cells by cyclic AMP-dependent protein kinase. Brain Res 481: 399–402
Lin B, Dietrich WD, Busto R, Ginsberg MD (1990): (s)-Emopamil protects against global ischemic brain injury in rats. Stroke 21: 1734–1739
Madden KP, Clark WM, Kochhar A, Zivin JA (1991): Effect of protein kinase C modulation on outcome of experimental CNS ischemia. Brain Res 547: 193–198
Malenka RC, Madison DV, Nicoll RA (1986): Potentiation of synaptic transmission in the hippocampus by phorbol esters. Nature 321: 175–177
Manev H, Favaron M, Vicini S, Guidotti A, Costa E (1990): Glutamate-induced neuronal death in primary cultures of cerebellar granule cells: Protection by synthetic derivatives of endogenous sphingolipids. J Pharmacol Exp Ther 252: 419–427
Marchi M, Bocchieri P, Garbarino L, Raiteri M (1989): Muscarinic inhibition of endogenous glutamate release from rat hippocampus synaptosomes. Neurosci Lett 96: 229–234
Markwell MAK, Berger SP, Paul SM (1990): The polyamine synthesis inhibitor a-difluoromethylornithine blocks NMDA-induced neurotoxicity. Eur J Pharmacol 182: 607–609
Martin D, Bustos GA, Bowe MA, Bray SD, Nadler JV (1991): Autoreceptor regulation of glutamate and aspartate release from slices of the hippocampal CA1 area. J Neurochem 56: 1647–1655
Masu M, Tanabe Y, Tsuchida K, Shigemoto R, Nakanishi S (1991): Sequence and expression of a metabotropic glutamate receptor. Nature 349: 760–765
Mayer ML (1991): Physiology and biophysics of the NMDA receptor channel complex. In: Excitatory Amino Acid Antagonists, Meldrum BS, ed, p. 64. Blackwell Scientific Publications, Oxford
McDonald JW, Silverstein FS, Johnston MV (1987): MK-801 protects the neonatal brain from hypoxic-ischemic damage. Eur J Pharmacol 140: 359–361
Meldrum BS (1990): Protection against ischemic neuronal damage by drugs acting on excitatory neurotransmission. Cerebrovasc Brain Metab Rev 2: 27–57
Meldrum BS, ed (1991): Excitatory Amino Acid Antagonists Oxford: Blackwell Scientific Publications
Meldrum BS, Garthwaite J (1990): Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol Sci 11: 379–387
Meldrum BS, Swan JH, Leach MJ, Millan MH, Gwinn R, Kadota K, Graham SH, Chen J, Simon RP (1992): Reduction of glutamate release and protection against ischemic brain damage by BW 1003C87. Brain Res (in press)
Meldrum BS, Swan JH, Millan MH, Leach MJ, Gwinn R, Kadota K, Graham SH, Simon RP (1991): A pyrimidine derivative, BW 1003C87, decreases glutamate release and protects against ischemic damage. In: The Role of Neurotransmitters in Brain Injury, Dietrich WD, Globus M Y-T, eds. New York: Plenum Publishing Corporation (in press)
Michenfelder JD, Lanier WL, Scheithauer BW, Perkins WJ, Shearman GT, Milde JH (1989): Evaluation of the glutamate antagonist dizocilipine maleate (MK-801) on neurologic outcome in a canine model of complete cerebral ischemia: correlation with hippocampal histopathology. Brain Res 481: 228–234
Miyamoto M, Coyle JT (1990): Idebenone attenuates neuronal degeneration induced by intrastriatal injection of excitotoxins. Exp Neurol 108, 38–45
Miyamoto M, Murphy TH, Sartre A, Schnaar RL, Coyle JT (1989): Antioxidants protect against glutamate-induced cytotoxicity in a neuronal cell line. J Pharmacol Exp Ther 250: 1132–1140
Moriyoshi K, Masu M, Ishii T, Shigemoto R, Mizuno N, Nakanishi S (1991): Molecular cloning and characterization of the rat NMDA receptor. Nature 354: 31–37
Mouradian RD, Sessler FM, Waterhouse BD (1991): Noradrenergic potentiation of excitatory transmitter action in cerebrocortical slices: Evidence for mediation by an alpha, receptor-linked second messenger pathway. Brain Res 546: 83–95
Mulder AH, Burger DM, Wardeh G, Hogenboom F, Frankhuyzen AL (1991): Pharmacological profile of various kappa-agonists at kappa-, mu-and deltaopioid receptors mediating presynaptic inhibition of neurotransmitter release in the rat brain. Br J Pharmacol 102: 518–522
Nicholls D, Attwell D (1990): The release and uptake of excitatory amino acids. Trends Pharmacol Sci 11: 462–467
Nichols RA, Sihra TS, Czernik AJ, Nairn AC, Greengard P (1990): Calcium/ calmodulin-dependent protein kinase II increases glutamate and noradrenaline release from synaptosomes. Nature 343: 647–651
Nuglisch J, Karkoutly C, Peruche B, Prehn JHM, Welsch M, Mennel HD, Rossberg C, Krieglstein J (1990): Effect of the 5-HT 1A-agonist CM57493 on infarct area, infarct volume and hippocampal neuronal damage after focal and global cerebral ischemia in mice and in rats. In: Pharmacology of Cerebral Ischemia 1990, Krieglstein J, Oberpichler H, eds. Stuttgart: Wissenschaftliche Verlagsgesellschaft, p 493
Olney JW (1990): Excitotoxic amino acids and neuropsychiatric disorders. Annu Rev Pharmacol Toxicol 30: 47–71
Olney JW, Ikonomidou C, Mosinger JL, Friedrich G (1989): MK-801 prevents hypobaric-ischemic neuronal degeneration in infant rat brain. J Neurosci 9: 1701–1704
Ouardouz M, Durand J (1991): GYKI 52466 antagonizes glutamate responses but not NMDA and kainate responses in rat abducens motoneurones. Neurosci Lett 125: 5–8
Ozyurt E, Graham DI, Woodruff GN, McCulloch J (1988): Protective effect of the glutamate antagonist, MK-801 in focal cerebral ischemia in the cat. J Cereb Blood Flow Metab 8: 138–143
Palfreyman MG, Baron BM (1991): Non-competitive NMDA antagonists acting on the glycine site. In: Excitatory Amino Acid Antagonists, Meldrum BS, ed. Oxford: Blackwell Scientific Publications, p 101
Park CK, Nehls DG, Graham DI, Teasdale GM, McCulloch J (1988a): The glutamate antagonist MK-801 reduces focal ischemic damage in the rat. Ann Neurol24, 543–551
Park CK, Nehls DG, Graham DI, Teasdale GM, McCulloch J (1988b): Focal cerebral ischemia in the cat: treatment with the glutamate antagonist MK-801 after induction of ischemia. J Cereb Blood Flow Metab 8: 757–762
Paschen W, Rohn G, Meese CO, Pjunicie B, Schmidt-Kastner R (1991): Polyamine metabolism in reversible cerebral ischemia: Effects of a-difluoromethylornithine. Brain Res 453: 9–16
Pellegrini-Giampietro DE, Cherici G, Alesiani M, Carla V, Moroni F (1990): Excitatory amino acid release and free radical formation may cooperate in the genesis of ischemia-induced neuronal damage. J Neurosci 10: 1035–1041
Phillis JW, Walter GA, Simpson RE (1991): Brain adenosine and transmitter amino acid release from the ischemic rat cerebral cortex: Effects of the adenosine deaminase inhibitor deoxycoformycin. J Neurochem 56: 644–650
Prince DA, Feeser HR (1988): Dextromethorphan protects against cerebral infarc-tion in a rat model of hypoxia-ischemia. Neurosci Lett 85: 291–296
Rice JE, Vannucci RC, Brierley JB (1981): The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann Neurol 9: 131–141
Rod MR, Auer RN (1989): Pre-and post-ischemic administration of dizocilpine (MK-801) reduces cerebral necrosis in the rat. Can J Neurol Sci 16: 340–344
Roman R, Bartkowski H, Simon R (1989): The specific NMDA receptor antagonist AP-7 attenuates focal ischemic brain injury. Neurosci Lett 104: 19–24
Seren MS, Rubini R, Lazzaro A, Zanoni R, Fiori MG, Leon A (1990): Protective effects of a monosialoganglioside derivative following transitory forebrain ischemia in rats. Stroke 21: 1607–1612
Seubert P, Lee K, Lynch G (1989): Ischemia triggers NMDA receptor-linked cytoskeletal proteolysis in hippocampus. Brain Res 492: 366–370
Sheardown MJ, Nielsen EO, Hansen AJ, Jacobsen P, Honoré T (1990): 2,3Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: A neuroprotectant for cerebral ischemia. Science 247: 571–574
Silvia RC, Slizgi GR, Ludens JH, Tang AH (1987): Protection from ischemia-induced cerebral edema in the rat by U-50488H, a kappa opioid receptor agonist. Brain Res 403: 52–57
Siman R (1990): Role of calpain I in excitatory amino acid-induced degenerative structural changes. In: Neurotoxicity of Excitatory Amino Acids, Guidotti A, ed. New York: Raven Press, p 145
Siman R, Noszek JC, Kegerise C (1989): Calpain I activation is specifically related to excitatory amino acid induction of hippocampal damage. J Neurosci 9: 1579–1590
Simmonds MA, Horne AL (1988): Barbiturates and excitatory amino acid interactions. In: Excitatory Amino Acids in Health and Disease, Lodge D, ed. Chichester: John Wiley & Sons, p 219
Swan JH, Evans MC, Meldrum BS (1988): Long-term development of selective neuronal loss and the mechanism of protection by 2-amino-7-phosphonoheptanoate in a rat model of incomplete forebrain ischemia. J Cereb Blood Flow Metab 8: 64–78
Swan JH, Meldrum BS (1990): Protection by NMDA antagonists against selective cell loss following transient ischemia. J Cereb Blood Flow Metab 10: 343–351
Takata Y, Ozawa J, Kato H (1991): A selective effect of protein kinase C activators on noradrenaline release compared with subsequent contraction in canine isolated saphenous veins. Brit J Pharmacol 102: 955–961
Tarnawa I, Engberg I, Flatman JA (1990): GYKI 52466, an inhibitor of spinal reflexes is a potent quiqualate antagonist. In: Amino Acids. Chemistry, Biology, and Medicine, Lubec G, Rosenthal GA, eds. Leiden: Escom, p 538
Turner JP, Meldrum BS (1991): L-Glutamate diethyl ester and deaminated analogues as excitatory amino acid antagonists in rat cerebral cortex. Brit J Pharmacol 104: 445–451
Warner MA, Nadler JV, Crain BJ (1990): Effects of NMDA receptor antagonists and body temperature in the gerbil carotid occlusion model of transient forebrain ischemia. In: Current and Future Trends in Anticonvulsant Anxiety and Stroke Therapy, Meldrum BS, Williams M, eds. New York: Alan R. Liss
Watkins JC (1991): Structure/activity relations of competitive NMDA receptor antagonists. In: Excitatory Amino Acid Antagonists, Meldrum BS, ed. Oxford: Blackwell Scientific Publications, p 84
Watkins JC, Evans RH (1981): Excitatory amino acid transmitters. Annu Rev Pharmacol Toxicol 21: 165–204
Wong RKS (1990): Intracellular Ca2+: Glutamate-induced elevation and role as a messenger in hippocampal pyramidal cells. In: Neurotoxicity of Excitatory Amino Acids, Guidotti A, ed. New York: Raven Press, p 19
Wood PL, Emmett MR, Rao TS, Cler J, Mick S, Iyengar S (1990): Inhibition of nitric oxide synthase blocks N-methyl-D-aspartate-, quisqualate-, kainate-, harmaline-, and pentylenetetrazole-dependent increases in cerebellar cyclic GMP in vivo. J Neurochem 55: 346–348
Wroblewski JT, Blaker WD, Meek JL (1985): Ornithine as a precursor of neurotransmitter glutamate: Effect of canaline on ornithine aminotransferase activity and glutamate content in the septum of rat brain. Brain Res 329: 161–168
Xiang J-Z, Adamson P, Brammer MJ, Campbell IC (1990): The kappa-opiate agonist U50488H decreases the entry of 45Ca into rat cortical synaptosomes by inhibiting N- but not L-type calcium channels. Neuropharmacology 29: 439–444
Xiang J-Z, Brammer MJ, Campbell IC (1991): Quisqualate and carbachol-induced increases in intrasynaptosomal free calcium are mediated by different products of phospholipid hydrolysis. Mol Pharmacol 207: 93–100
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Birkhäuser Boston
About this chapter
Cite this chapter
Meldrum, B. (1992). Excitatory Amino Acids and Neuroprotection. In: Marangos, P.J., Lal, H. (eds) Emerging Strategies in Neuroprotection. Advances in Neuroprotection, vol 22. Birkhäuser, Boston, MA. https://doi.org/10.1007/978-1-4684-6796-3_7
Download citation
DOI: https://doi.org/10.1007/978-1-4684-6796-3_7
Published:
Publisher Name: Birkhäuser, Boston, MA
Print ISBN: 978-1-4684-6798-7
Online ISBN: 978-1-4684-6796-3
eBook Packages: Springer Book Archive